Pete Clarner

Pete Clarner

Company: Biogen

Job title: Senior Associate Scientist, Gene Therapy Accelerator Unit


Pete graduated with a Bachelor’s degree in Biology from Boston College and a Professional Science Master’s degree in Biotechnology from Northeastern University. For 7 years he was a member of the Bioassay and Gene Therapy group within the Analytical Development department at Biogen. There he supported the characterization and development of protein biologic and AAV vector-based gene therapy programs. He has specific expertise in PCR-based methods including ddPCR and qPCR. He recently joined the Gene Therapy Accelerator Unit within the Biotherapeutics and Medicinal Sciences department at Biogen. There he continues to focus on vector analytics as well as supports portfolio and technology development.


PCR-based Approaches for Determining AAV Genome Titer in Support of Gene Therapy Development 11:30 am

The criticality of genome titer assays at all different stages of development The advantages and disadvantages of ddPCR and qPCR for gene therapy vector titering and development support Strategies for method crossover and when to apply a platformRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.